americanwire
Chinese President Xi Jinping is sticking with lockdowns while the West returns to normalcy because China’s national vaccine is relatively ineffective at protecting against COVID-19, a medical expert told The Daily Caller News Foundation.
China’s lockdowns, missing vaccine drug trial data and the failure of its “vaccine diplomacy” program are evidence that Sinopharm, China’s national pharmaceutical company, developed and marketed an inferior vaccine, Prof. Peter Pitts, president of the Center for Medicine in the Public Interest, told TheDCNF. Pitts argued that Sinopharm’s vaccine exposes patients who contract COVID-19 to greater health risks than what individuals who have received vaccines developed in the U.S. would face.
“You don’t lock down your country for an endemic where the symptoms are mild and the length is transient. You lock down your economy for a deadly pandemic,” Pitts said. “They must know something that we don’t know, which is that their vaccine is not working.”
Pitts told TheDCNF during his career he’d often interacted with China’s National Medical Products Administration and also testified before Congress on issues related to counterfeit drugs in China.
Pitts pointed to China’s lockdowns as one of three indicators Sinopharm’s vaccine is “subpar.”
Despite food shortages, protests, looting and an announcement 15 districts had achieved zero transmissions Tuesday, many residents of Shanghai, China’s financial hub, have reportedly remained in lockdown since April 5. Meanwhile, Beijing residents reportedly fear a city-wide lockdown, following an outbreak in Chaoyang district which began some time before April 24, according to Reuters.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…